Unknown

Dataset Information

0

Immune Checkpoint Inhibitors for Urothelial Cancer: An Update on New Therapies.


ABSTRACT: Ongoing trials are evaluating immune checkpoint inhibitors-used alone, in combination with cytotoxic, targeted, radiation therapies, or with other such inhibitors-for therapy in patients with advanced bladder cancer.

SUBMITTER: El-Mouallem N 

PROVIDER: S-EPMC6248150 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Immune Checkpoint Inhibitors for Urothelial Cancer: An Update on New Therapies.

El-Mouallem Nemer N   Paul Asit K AK  

Federal practitioner : for the health care professionals of the VA, DoD, and PHS 20180801 Suppl 5


Ongoing trials are evaluating immune checkpoint inhibitors-used alone, in combination with cytotoxic, targeted, radiation therapies, or with other such inhibitors-for therapy in patients with advanced bladder cancer. ...[more]

Similar Datasets

| S-EPMC6121021 | biostudies-literature
| S-EPMC5993034 | biostudies-literature
| S-EPMC8276975 | biostudies-literature
| S-EPMC5323287 | biostudies-literature
| S-EPMC7694085 | biostudies-literature
| S-EPMC8122430 | biostudies-literature
| S-EPMC8431680 | biostudies-literature
| S-EPMC8081349 | biostudies-literature
| S-EPMC4943092 | biostudies-literature